甲状腺乳头状癌中央区淋巴结转移的相关临床因素分析
Analysis of Clinical Factors Related to Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
DOI: 10.12677/acm.2024.1461869, PDF,   
作者: 方中音, 梅金玉*:安徽医科大学第二附属医院耳鼻咽喉–头颈外科,安徽 合肥
关键词: 甲状腺乳头状癌中央区淋巴结转移Logistic回归分析Papillary Thyroid Carcinoma Central Lymph Node Metastasis Logistic Regression Analysis
摘要: 目的:分析不同因素对甲状腺乳头状癌患者中央区淋巴结转移的影响,从而帮助医生们能从多角度分析,成为术中是否行中央区淋巴结清扫的依据。方法:收集2022年6月至2024年2月就诊于安徽医科大学第二附属医院的甲状腺乳头状癌患者,共76例,收集一般资料,包括:性别、年龄;肿瘤相关特征包括:肿瘤双侧性、是否多发病灶、肿瘤大小、与被膜距离关系、BRAF基因突变情况;超声检查结果包括:肿瘤位置、纵横比、有无血流通过、钙化情况。应用SPSS软件(版本25.0)对收集数据进统计学分析,中央区淋巴结转移阳性组和阴性组的组间比较,分类资料使用卡方检验,计量资料比较采用t检验,方差不齐时采用秩和检验。采用多因素Logistic回归分析法进行中央区淋巴结转移相关临床危险因素的分析。结果:单因素回归分析提示:在甲状腺乳头状癌中央区淋巴结转移组与未转移组间肿瘤大小、原发肿瘤为单发或多发、是否伴钙化总体分布均存在显著性差异(p < 0.05),有统计学意义。而年龄、性别、双侧性、肿瘤与被膜间距离、BRAF基因是否突变、肿瘤位置、有无血流通过在两组间无显著性差异(p > 0.05),无统计学意义。对因素进行多因素Logistic回归分析,变量进入方法为逐步进入法,得出肿瘤大小具有显著性差异(p < 0.05),是影响中央区淋巴结转移的独立因素。根据OR值可知,肿瘤越大的患者出现中央区淋巴结转移的可能性更高。结论:术前超声检查提示甲状腺乳头状癌直径大、多发、伴有钙化的发生中央区淋巴结转移可能性较大,对术前超声未提示中央区淋巴结转移患者,术中是否行预防性颈部淋巴结清扫有着借鉴作用,从而减小甲状腺乳头状癌患者术后复发可能,改善部分患者由于复发所致生存质量及生存时间的降低,对患者术后生活质量提高有着积极意义,所以,术前进行良好的颈部淋巴结转移评估有着极其重要的临床意义。
Abstract: Objective: To analyze the effects of different factors on central lymph node metastasis in patients with papillary thyroid carcinoma, so as to help doctors analyze whether to perform intraoperative central lymph node exploration and dissection from multiple perspectives. Methods: A total of 76 patients with thyroid nodules who were admitted to the Second Affiliated Hospital of Anhui Medical University from June 2022 to February 2024 were selected, and general data, including gender and age, were collected. Tumor-related characteristics, including bilateral tumor, multiple lesions, tu-mor size, distance from the capsule, BRAF gene mutations; ultrasonography findings, including tu-mor location, aspect ratio, presence or absence of blood flow, and calcifications. SPSS software (ver-sion 25.0) was used for statistical analysis of the collected data, and the group was compared be-tween the positive and negative groups for central lymph node metastasis, and the chi-square test was used for categorical data, the t-test was used for continuous data comparison, and the rank-sum test was used for irregular variance. Multivariate Logistic regression analysis was used to analyze the clinical risk factors related to lymph node metastasis in the central region. Results: Univariate regression analysis showed that there were significant differences in tumor size, single or multiple primary tumors, and whether there was calcification between the central lymph node metastasis group and the non-metastasis group of papillary thyroid carcinoma (p < 0.05). There were no sig-nificant differences in age, gender, bilaterality, distance from the capsule, BRAF gene mutation, tu-mor location, and blood flow between the two groups (p > 0.05) with statistical significance. Multi-variate Logistic regression analysis was performed, and the variable entry method was stepwise entry method, and it was concluded that there was a significant difference in tumor size (p < 0.05), without statistical significance, which was an independent factor affecting lymph node metastasis in the central region. Based on the OR value, patients with larger ultrasound aspect ratios are more likely to have central lymph node metastases. Conclusions: Preoperative ultrasound examination showed that the thyroid tumor was larger, more frequent and with calcification, and the central lymph node metastasis was more likely, which has a positive significance for the improvement of postoperative quality of life for patients with no central lymph node malignancy in preoperative ul-trasound, so as to reduce the potential recurrence of papillary thyroid carcinoma patients after surgery, improve the quality of life and the reduction of survival time due to recurrence in some pa-tients, and improve the postoperative quality of life of patients. A good preoperative assessment of cervical lymph node metastases is of great clinical significance.
文章引用:方中音, 梅金玉. 甲状腺乳头状癌中央区淋巴结转移的相关临床因素分析[J]. 临床医学进展, 2024, 14(6): 990-999. https://doi.org/10.12677/acm.2024.1461869

参考文献

[1] 甲状腺癌诊疗指南(2022年版) [J].中国实用外科杂志, 2022, 42(12): 1343-1357+1363. [Google Scholar] [CrossRef
[2] Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]
[3] Randolph, G.W., Duh, Q., Heller, K.S., LiVolsi, V.A., Mandel, S.J., Steward, D.L., et al. (2012) The Prognostic Significance of Nodal Metastases from Papillary Thyroid Carcinoma Can Be Stratified Based on the Size and Number of Metastatic Lymph Nodes, as Well as the Presence of Extranodal Extension. Thyroid, 22, 1144-1152. [Google Scholar] [CrossRef] [PubMed]
[4] Machens, A., Hinze, R., Thomusch, O. and Dralle, H. (2001) Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer. World Journal of Surgery, 26, 22-28. [Google Scholar] [CrossRef] [PubMed]
[5] Carling, T., Carty, S.E., Ciarleglio, M.M., Cooper, D.S., Doherty, G.M., Kim, L.T., et al. (2012) American Thyroid Association Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph Node Dissection for Papillary Thyroid Carcinoma. Thyroid, 22, 237-244. [Google Scholar] [CrossRef] [PubMed]
[6] Seib, C.D. and Sosa, J.A. (2019) Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinology and Metabolism Clinics of North America, 48, 23-35. [Google Scholar] [CrossRef] [PubMed]
[7] Shin, J.H., Baek, J.H., Chung, J., Ha, E.J., Kim, J., Lee, Y.H., et al. (2016) Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean Journal of Radiology, 17, 370-395. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, X., Zhu, L., Wang, Z., Cui, D., Chen, H., Duan, Y., et al. (2016) Evolutionary Features of Thyroid Cancer in Patients with Thyroidectomies from 2008 to 2013 in China. Scientific Reports, 6, Article No. 28414. [Google Scholar] [CrossRef] [PubMed]
[9] Lee, D.W., Ji, Y.B., Sung, E.S., Park, J.S., Lee, Y.J., Park, D.W., et al. (2013) Roles of Ultrasonography and Computed Tomography in the Surgical Management of Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma. European Journal of Surgical Oncology (EJSO), 39, 191-196. [Google Scholar] [CrossRef] [PubMed]
[10] Hong, Y., Luo, Z., Mo, G., Wang, P., Ye, Q. and Huang, P. (2017) Role of Contrast-Enhanced Ultrasound in the Pre-Operative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma. Ultrasound in Medicine & Biology, 43, 2567-2575. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, H. and Li, H. (2019) Meta-Analysis of Ultrasound for Cervical Lymph Nodes in Papillary Thyroid Cancer: Diagnosis of Central and Lateral Compartment Nodal Metastases. European Journal of Radiology, 112, 14-21. [Google Scholar] [CrossRef] [PubMed]
[12] Papaleontiou, M., Chen, D.W., Banerjee, M., Reyes-Gastelum, D., Hamilton, A.S., Ward, K.C., et al. (2021) Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study. Thyroid, 31, 1383-1390. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, Q., Li, J., Shen, H., Bai, X., Zhang, T. and Liu, P. (2022) Screening and Validation of Lymph Node Metastasis Risk-Factor Genes in Papillary Thyroid Carcinoma. Frontiers in Endocrinology, 13, Article ID: 991906. [Google Scholar] [CrossRef] [PubMed]
[14] Verburg, F.A., Mäder, U., Tanase, K., Thies, E., Diessl, S., Buck, A.K., et al. (2013) Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients. The Journal of Clinical Endocrinology & Metabolism, 98, 172-180. [Google Scholar] [CrossRef] [PubMed]
[15] Ito, Y., Miyauchi, A., Kihara, M., Takamura, Y., Kobayashi, K. and Miya, A. (2012) Relationship between Prognosis of Papillary Thyroid Carcinoma Patient and Age: A Retrospective Single-Institution Study. Endocrine Journal, 59, 399-405. [Google Scholar] [CrossRef] [PubMed]
[16] Haddad, R.I., Nasr, C., Bischoff, L., Busaidy, N.L., Byrd, D., Callender, G., et al. (2018) NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. Journal of the National Comprehensive Cancer Network, 16, 1429-1440. [Google Scholar] [CrossRef] [PubMed]
[17] Shao, Y., Cai, X.J., Gao, L., Li, H. and Xie, L. (2009) Clinical Factors Related to Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Clinical Analysis of 117 Cases. National Medical Journal of China, 89, 403-405.
[18] Radowsky, J.S., Howard, R.S., Burch, H.B. and Stojadinovic, A. (2014) Impact of Degree of Extrathyroidal Extension of Disease on Papillary Thyroid Cancer Outcome. Thyroid, 24, 241-244. [Google Scholar] [CrossRef] [PubMed]
[19] Park, J.S., Chang, J.W., Liu, L., Jung, S. and Koo, B.S. (2017) Clinical Implications of Microscopic Extrathyroidal Extension in Patients with Papillary Thyroid Carcinoma. Oral Oncology, 72, 183-187. [Google Scholar] [CrossRef] [PubMed]
[20] Kuo, S., Lin, S., Chao, T., Hsueh, C., Lin, K. and Lin, J. (2013) Prognosis of Multifocal Papillary Thyroid Carcinoma. International Journal of Endocrinology, 2013, Article ID: 809382. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, W., Gu, J., Shang, J. and Wang, K. (2013) Correlation Analysis on Central Lymph Node Metastasis in 276 Patients with cN0 Papillary Thyroid Carcinoma. International Journal of Clinical and Experimental Pathology, 6, 510-515.